Spero Therapeutics
(NASDAQ) SPRO
Spero Therapeutics Financials at a Glance
Market Cap
$140.68M
Revenue (TTM)
$60.38M
Net Income (TTM)
$8.57M
EPS (TTM)
$0.12
P/E Ratio
20.42
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$2.44
Volume
214,374
Open
$2.41
Price
$2.44
Volume
214,374
Open
$2.41
Previous Close
$2.43
Daily Range
$2.38 - $2.45
52-Week Range
$0.51 - $3.22
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$2.44
Volume
214,374
Open
$2.41
Previous Close
$2.43
Daily Range
$2.38 - $2.45
52-Week Range
$0.51 - $3.22
SPRO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Spero Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
25
CEO
Esther Rajavelu, MBA
Website
www.sperotherapeutics.comHeadquarters
Cambridge, MA 02139, US
SPRO Financials
Key Financial Metrics (TTM)
Gross Margin
77%
Operating Margin
-0%
Net Income Margin
14%
Return on Equity
16%
Return on Capital
-0%
Return on Assets
12%
Earnings Yield
4.90%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$140.68M
Shares Outstanding
57.89M
Volume
214.37K
Short Interest
0.00%
Avg. Volume
313.58K
Financials (TTM)
Gross Profit
$59.62M
Operating Income
$24.00K
EBITDA
$24.00K
Operating Cash Flow
$12.62M
Capital Expenditure
$0.00
Free Cash Flow
$12.62M
Cash & ST Invst.
$40.27M
Total Debt
$2.90M
Spero Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$39.66M
+163.6%
Gross Profit
$39.66M
+149.8%
Gross Margin
100.00%
N/A
Market Cap
$140.68M
N/A
Market Cap/Employee
$4.40M
N/A
Employees
32
N/A
Net Income
$31.52M
+250.9%
EBITDA
$29.77M
+242.8%
Quarterly Fundamentals
Net Cash
$37.37M
-23.1%
Accounts Receivable
$25.39M
-51.6%
Inventory
$0.00
N/A
Long Term Debt
$939.00K
-63.2%
Short Term Debt
$1.96M
+12.0%
Return on Assets
12.44%
N/A
Return on Invested Capital
-0.04%
N/A
Free Cash Flow
$8.35M
+64.3%
Operating Cash Flow
$8.35M
+64.3%